News

Swedish Orphan Biovitrum has been granted Orphan Drug Designation (ODD) by the U.S. Food and Drug Administration (FDA) for the company’s development candidate SOBI003, a chemically…
Read More...

Exscientia, an innovative company at the forefront of Artificial Intelligence (AI)-driven drug discovery, is pleased to announce it has entered into a strategic drug discovery…
Read More...

Sun Pharma and Samsung BioLogics announced a strategic long-term manufacturing agreement for Tildrakizumab. The agreement was entered into by Sun Pharma's wholly-owned subsidiary and…
Read More...

Endo International plc announced that it has completed the previously announced divestiture of its South African based operations, Litha Healthcare Group, to Acino Pharma AG. In…
Read More...

Arbor Pharmaceuticals, LLC, a U.S.-based specialty pharmaceutical company, and Debiopharm International SA, part of Debiopharm Group™, a Swiss-based global biopharmaceutical company,…
Read More...

CordenPharma International and GE Healthcare’s Dharmacon business have entered a strategic collaboration to create an end-to-end solution for oligonucleotide-based drug discovery.…
Read More...

Valeant Pharmaceuticals announced that its affiliate has completed the sale of all of the outstanding equity interests in its former subsidiary Dendreon Pharmaceuticals LLC to the…
Read More...

Trovagene, a precision medicine biotechnology company, announced it has executed a supplier agreement with NerPharMa, S.r.l., a pharmaceutical manufacturing company and a subsidiary of…
Read More...

Glytec, the healthcare company behind a market-leading software solution for personalized diabetes therapy management, announces five new patent allowances for its eGlycemic Management…
Read More...

Bioverativ announced that it has successfully completed its acquisition of True North Therapeutics, a privately-held, clinical-stage rare disease biotechnology company. The acquisition…
Read More...

LivaNova announced that it received FDA approval of its VNS Therapy system in patients as young as four years of age with partial onset seizures that are refractory to antiepileptic…
Read More...

Casebia Therapeutics, the joint venture founded by Bayer and CRISPR Therapeutics, announced the hiring of Robin A. Walker as the company’s Vice President, Head of Legal. Walker is a…
Read More...

Veeva Systems announced that Santhera Pharmaceuticals selected Veeva CRM and Veeva OpenData as a commercial software and data platform for its first product launch. The rare disease…
Read More...

LifeArc, the UK medical research charity previously known as MRC Technology, The Centre for Drug Research and Development (CDRD), and the Defence Science and Technology Laboratory…
Read More...

NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd announced that the clinical phase I study of KL1333 has started in Korea and that the first healthy volunteer has been…
Read More...

QS Pharma, the Contract Development and Manufacturing Organisation (CDMO), which was acquired by Quotient Clinical in February 2017, announced it has received approval from the European…
Read More...

Allergan announced the launch of the over-the-counter (OTC) artificial tear REFRESH OPTIVE MEGA-3, the latest innovation in the REFRESH portfolio that fortifies the lipid layer when…
Read More...

Breckenridge Pharmaceutical, Inc. announced that FDA has granted final approval of its ANDA Azacitidine for Injection, 100mg per vial, Single-Dose Vial, a generic version of Vidaza® by…
Read More...

Danish drugmaker Novo Nordisk said on Friday a phase 2 trial for its big hope in tackling obesity, an improved GLP-1 drug called semaglutide, showed a weight loss of up to 13.8 percent…
Read More...

Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced that…
Read More...